Filing Details

Accession Number:
0001209191-23-019944
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-17 21:00:10
Reporting Period:
2023-03-15
Accepted Time:
2023-03-17 21:00:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1630627 Treace Medical Concepts Inc. TMCI Surgical & Medical Instruments & Apparatus (3841) 471052611
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1858105 E. Daniel Owens C/O Treace Medical Concepts, Inc.
100 Palmetto Park Place
Ponte Vedra FL 32081
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-15 6,250 $7.03 37,164 No 4 M Direct
Common Stock Disposition 2023-03-15 6,250 $22.87 30,914 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Stock Option Right To Buy Stock Option Right to Buy Disposition 2023-03-15 6,250 $0.00 6,250 $7.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
176,375 2031-02-02 No 4 M Direct
Footnotes
  1. The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. Includes 25,650 RSUs.
  3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.6600 to $23.3900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.